NervenarztPub Date : 2024-09-01Epub Date: 2024-06-21DOI: 10.1007/s00115-024-01688-4
P Falkai, T Frodl, H J Grabe, R Rupprecht, A Philipsen
{"title":"[Assessment of university psychiatry and psychotherapy in Germany: Responsibilities and challenges : Position paper of the Lehrstuhlinhaber für Psychiatrie und Psychotherapie e. V. (LIPPs) in Germany].","authors":"P Falkai, T Frodl, H J Grabe, R Rupprecht, A Philipsen","doi":"10.1007/s00115-024-01688-4","DOIUrl":"10.1007/s00115-024-01688-4","url":null,"abstract":"","PeriodicalId":49770,"journal":{"name":"Nervenarzt","volume":" ","pages":"853-860"},"PeriodicalIF":0.9,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11374917/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141433227","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
NervenarztPub Date : 2024-09-01Epub Date: 2024-06-26DOI: 10.1007/s00115-024-01692-8
Anne Koopmann, Ulrich S Zimmermann, Diana Moesgen
{"title":"[Family-focused treatment approaches for drug-addicted parents].","authors":"Anne Koopmann, Ulrich S Zimmermann, Diana Moesgen","doi":"10.1007/s00115-024-01692-8","DOIUrl":"10.1007/s00115-024-01692-8","url":null,"abstract":"<p><strong>Background: </strong>In Germany 1.5-2.75 million children live in families affected by substance use disorders. Substance abuse can impact on family interactions in many ways. If a dependent parental drug use continues over a longer period of time, this can have pronounced psychological and social consequences for the (co)affected children. Nevertheless, family-focused treatment approaches are not yet widely used in the context of addiction treatment.</p><p><strong>Aim: </strong>This review article aims to provide an overview of the prevalence of parenthood among dependent drug users in Germany, the impact of dependent drug use on families and family-focused treatment approaches.</p><p><strong>Methods and results: </strong>Recording parenthood is particularly difficult in the case of dependent drug users as they often do not openly discuss it with their therapists because of the fear of consequences from youth welfare services. In order to change this, a structured recording of parenthood by the treatment providers is required. This is the prerequisite for being able to offer family-focused treatment to those affected. In Germany, three evidence-based therapy programs are available for this purpose: SHIFT, SHIFT Plus and MAMADAM. Additionally, a number of programs developed in the Anglo-American region can also be used. In contrast, the evidence for web-based programs is much weaker.</p><p><strong>Discussion: </strong>In order to establish family-focused treatment approaches for drug-using parents across the board, long-term, secure funding is required. The necessary framework conditions must be created at a political level.</p>","PeriodicalId":49770,"journal":{"name":"Nervenarzt","volume":" ","pages":"830-835"},"PeriodicalIF":0.9,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141460320","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
NervenarztPub Date : 2024-08-26DOI: 10.1007/s00115-024-01726-1
Susanne Nehls, Juergen Dukart, Christian Enzensberger, Elmar Stickeler, Simon B Eickhoff, Natalia Chechko
{"title":"[Prediction and timely identification of postpartum depression: results of the longitudinal RiPoD study in the context of the literature].","authors":"Susanne Nehls, Juergen Dukart, Christian Enzensberger, Elmar Stickeler, Simon B Eickhoff, Natalia Chechko","doi":"10.1007/s00115-024-01726-1","DOIUrl":"https://doi.org/10.1007/s00115-024-01726-1","url":null,"abstract":"<p><p>The first 4-6 weeks after childbirth are defined as the onset time for postpartum depression (PPD). Despite this known time frame there are significant gaps in the identification and treatment of PPD. The risk for postpartum depression (RiPoD) study investigated specific risk factors and predictors of postpartum psychological adjustment processes and the results are presented within the framework of a state of the art review of research. The dynamic neuroplastic changes in the maternal brain during pregnancy and the postpartum period appear to be closely linked to peripartum hormone fluctuations, which jointly influence the development of postpartum mood disorders. Hormonal risk factors such as baby blues and premenstrual syndrome have been found to have a bearing on PPD. The combination of these two factors predicts the risk of PPD with 83% sensitivity within the first week postpartum. Follow-up digital monitoring of symptom development in the first 6 weeks postpartum has enabled an accurate identification of women with PPD. Understanding the interaction between hormone fluctuations, neuroplasticity and psychiatric disorders should be an important target for future research. Early identification and diagnosis of PPD can be easily integrated into the clinical routine and everyday life.</p>","PeriodicalId":49770,"journal":{"name":"Nervenarzt","volume":" ","pages":""},"PeriodicalIF":0.9,"publicationDate":"2024-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142057088","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
NervenarztPub Date : 2024-08-22DOI: 10.1007/s00115-024-01714-5
Ulrich S Zimmermann, Clemens Plickert, Christel Lüdecke, Markus Stuppe, Christian Rosenbeiger, Yvonne Krisam, Tobias Link, Jean Keller, Gero Bühler, Deborah Scholz-Hehn, Ursula Havemann-Reinecke, Dirk Wedekind, Mathias Luderer, Maik Spreer
{"title":"[Patient and quality characteristics in the treatment with disulfiram (Antabus) in the German \"Network for Alcohol Aversive Pharmacotherapy\"].","authors":"Ulrich S Zimmermann, Clemens Plickert, Christel Lüdecke, Markus Stuppe, Christian Rosenbeiger, Yvonne Krisam, Tobias Link, Jean Keller, Gero Bühler, Deborah Scholz-Hehn, Ursula Havemann-Reinecke, Dirk Wedekind, Mathias Luderer, Maik Spreer","doi":"10.1007/s00115-024-01714-5","DOIUrl":"https://doi.org/10.1007/s00115-024-01714-5","url":null,"abstract":"<p><strong>Background: </strong>More than a decade ago disulfiram lost its approval for use in Germany. Nonetheless, a considerable number of psychiatric hospital outpatient departments as well as practicing physicians continue to prescribe it. These professionals have formed the \"Network for Alcohol Aversive Pharmacotherapy\" (NAP) to maintain a high quality of this treatment approach.</p><p><strong>Objective: </strong>To describe the current use of disulfiram with respect to patient numbers and characteristics, side effects, and use of concomitant multimodal treatment forms.</p><p><strong>Material and methods: </strong>Since 2019 the NAP has conducted an annual retrospective survey among its members regarding the aforementioned parameters.</p><p><strong>Results: </strong>From 2019 to 2023 a total of 1579 treatment cases were described by 33 centers, 152 patients reported a total of 241 drinking events, 26 of them resulting in hospitalization but none causing complications or permanent harm. The most frequent side effects, in descending order, were unpleasant body odor (2.5%), fatigue, male sexual dysfunction, mildly elevated liver enzymes, allergic skin reactions and polyneuropathy (0.8%). More than one quarter of the patients suffered from comorbid depression, and approximately 5% from ADHD, borderline or other personality disorders, trauma-related disorders and anxiety disorders, respectively. Of the patients 33% were treated with antidepressants and 12% with sedating antipsychotics. Various forms of concomitant group therapy were offered to 66% of the patients.</p><p><strong>Conclusion: </strong>Treatment with disulfiram is legally possible, generally well-tolerated and safe. It is offered in most treatment centers as part of a comprehensive treatment plan that includes multimodal treatment of comorbid psychiatric disorders.</p>","PeriodicalId":49770,"journal":{"name":"Nervenarzt","volume":" ","pages":""},"PeriodicalIF":0.9,"publicationDate":"2024-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142019335","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
NervenarztPub Date : 2024-08-22DOI: 10.1007/s00115-024-01720-7
Martin Hautzinger
{"title":"[Relapse prevention of bipolar disorders: an explorative cluster analytical approach in a randomized controlled psychotherapy study].","authors":"Martin Hautzinger","doi":"10.1007/s00115-024-01720-7","DOIUrl":"https://doi.org/10.1007/s00115-024-01720-7","url":null,"abstract":"<p><p>The aim of this study was to differentiate between types of bipolar disorders and the associated features using explorative analysis. The focus was particularly on the role of bipolar 1 and bipolar 2 disorders as well as the influence of prophylactic interventions for relapse in a randomized, controlled treatment study. A total of 274 of the 305 originally included persons could be investigated in the study. Patients participated in either cognitive behavioral group therapy (SEKT) or supportive, patient-centered group therapy (FEST). Treatment took place over 4 days separated by a 1-month interval (equivalent to 16 double hours). Depressive and manic symptoms were assessed using the longitudinal interval follow-up evaluation (LIFE). The symptoms were retrospectively assessed for the previous 6 months, with respect to each week before and after the intervention phase and for 6‑month and 12-month follow-ups. The results show that the effects of both group therapies were comparable; however, there were statistically significant differences in a multivariate proportional hazards model for the factors bipolar 1 and 2 as well as the interaction of therapy with bipolar 1 and 2. In particular, bipolar 2 patients benefited significantly less from the SEKT intervention than from the FEST intervention. There were three clusters identified that separated bipolar 1 (SEKT, no comorbidity, predominantly no recurrences, younger patients), from bipolar 2 (FEST, no comorbidity, at least 1 often 2 recurrences, older patients) and from a heterogeneous group (SEKT and FEST, comorbidity). The distinction between bipolar 1 and bipolar 2 disorder is important and has so far not received sufficient attention. Bipolar 2 disorders generally have a worse course and respond particularly poorly to cognitive behavioral therapy (SEKT). An open, unstructured, supportive, patient-centered psychotherapy (FEST) is generally effective.</p>","PeriodicalId":49770,"journal":{"name":"Nervenarzt","volume":" ","pages":""},"PeriodicalIF":0.9,"publicationDate":"2024-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142019336","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
NervenarztPub Date : 2024-08-21DOI: 10.1007/s00115-024-01719-0
Ulrich John, Hans-Jürgen Rumpf, Sabine Hoffmann, Christian Meyer, Falk Kiefer
{"title":"[Long-term courses of alcohol dependence].","authors":"Ulrich John, Hans-Jürgen Rumpf, Sabine Hoffmann, Christian Meyer, Falk Kiefer","doi":"10.1007/s00115-024-01719-0","DOIUrl":"https://doi.org/10.1007/s00115-024-01719-0","url":null,"abstract":"<p><strong>Background: </strong>Descriptions of long-term histories of alcohol dependence provide insight into the etiology, prevention and care.</p><p><strong>Objective: </strong>Report of empirical findings about the development into and remission from alcohol dependence.</p><p><strong>Method: </strong>Narrative literature review, analysis of findings from cohort studies in the general population.</p><p><strong>Results: </strong>Risk factors provide the opportunity to estimate increased probabilities of developing an alcohol dependence. Adolescents disclosed symptoms of alcohol dependence within 8 years after the first alcohol consumption. Alcohol dependence is related to a life expectancy 17.6 years fewer than in the general population. Data of a general population sample revealed a risk of early death 2.8 times higher than among people without mental disorders. The severity of alcohol dependence was shown to be a predictor of premature death. Nicotine dependence can add to the shortening of life in addition to alcohol dependence. Among the alcohol dependent residents in a general population sample, 90.2% did not have utilized detoxification treatment that included motivational treatment and 78.4% did not have utilized standard detoxification treatment in a psychiatric treatment facility. Remission without formal help has been proven. It is the main route of remission.</p><p><strong>Conclusion: </strong>To reduce unfavorable courses of alcohol dependence, prevention and treatment should be focused more on the needs in the general population. In psychiatric and other medical routine care, screening and an appropriate brief intervention should be carried out.</p>","PeriodicalId":49770,"journal":{"name":"Nervenarzt","volume":" ","pages":""},"PeriodicalIF":0.9,"publicationDate":"2024-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142019334","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
NervenarztPub Date : 2024-08-21DOI: 10.1007/s00115-024-01713-6
M Guhra, S H Kreisel, D Zilles-Wegner, A Sartorius, T Sappok, N Freundlieb
{"title":"[Electroconvulsive therapy in people with intellectual disability].","authors":"M Guhra, S H Kreisel, D Zilles-Wegner, A Sartorius, T Sappok, N Freundlieb","doi":"10.1007/s00115-024-01713-6","DOIUrl":"https://doi.org/10.1007/s00115-024-01713-6","url":null,"abstract":"<p><p>Electroconvulsive therapy (ECT) is a highly effective treatment option for severe mental illness. Although people with intellectual disability (ID) have similar prevalence rates of mental disorders in comparison to the general population their access to ECT remains challenging. A systematic literature review was carried out on treatment with ECT in patients with ID and a case report on a patient with ID who underwent ECT is presented, to highlight a typical clinical routine. A total of 100 articles with 208 different case reports were retrieved. In summary, the results underline the effectiveness of ECT in people with ID, with side effects comparable to those in the general population. The ECT is effective in the treatment of severe affective and psychotic disorders and particularly in people with catatonia. The use of ECT can improve the patient's mental health and quality of life and is often a life-saving treatment option. The prophylaxis of relapses should be included as early as possible in the planning process. Providing an easy access to ECT treatment for people with ID is corroborated by its effectiveness and is in line with the right to equal treatment in accordance with article 25 of the United Nations Convention on the Rights of Persons with Disabilities.</p>","PeriodicalId":49770,"journal":{"name":"Nervenarzt","volume":" ","pages":""},"PeriodicalIF":0.9,"publicationDate":"2024-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142141614","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
NervenarztPub Date : 2024-08-01Epub Date: 2024-06-11DOI: 10.1007/s00115-024-01681-x
Maike R Pollmanns, Jule K Adams, Manuel Dafotakis, Turgay Saritas, Christian Trautwein, Samira Abu Jhaisha, Alexander Koch
{"title":"[Course of neuron-specific enolase after resuscitation-When one value is of no value: a case report].","authors":"Maike R Pollmanns, Jule K Adams, Manuel Dafotakis, Turgay Saritas, Christian Trautwein, Samira Abu Jhaisha, Alexander Koch","doi":"10.1007/s00115-024-01681-x","DOIUrl":"10.1007/s00115-024-01681-x","url":null,"abstract":"","PeriodicalId":49770,"journal":{"name":"Nervenarzt","volume":" ","pages":"730-733"},"PeriodicalIF":0.9,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11297048/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141301975","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
NervenarztPub Date : 2024-08-01DOI: 10.1007/s00115-024-01712-7
{"title":"Mitteilungen der Deutschen Schlaganfall-Gesellschaft (DSG).","authors":"","doi":"10.1007/s00115-024-01712-7","DOIUrl":"https://doi.org/10.1007/s00115-024-01712-7","url":null,"abstract":"","PeriodicalId":49770,"journal":{"name":"Nervenarzt","volume":"95 8","pages":"773-778"},"PeriodicalIF":0.9,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141876513","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
NervenarztPub Date : 2024-08-01Epub Date: 2024-08-02DOI: 10.1007/s00115-024-01690-w
Lars Tönges
{"title":"[Facets of neurodegeneration : The fine art of diagnostic workup and individualized treatment].","authors":"Lars Tönges","doi":"10.1007/s00115-024-01690-w","DOIUrl":"https://doi.org/10.1007/s00115-024-01690-w","url":null,"abstract":"","PeriodicalId":49770,"journal":{"name":"Nervenarzt","volume":"95 8","pages":"687-688"},"PeriodicalIF":0.9,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141876512","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}